Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3847901 | American Journal of Kidney Diseases | 2015 | 4 Pages |
Abstract
Thrombotic microangiopathy (TMA) is a severe disorder with poor outcomes. The cause is unknown for many patients, although TMA is associated with connective tissue disorders, including systemic lupus erythematosus (SLE). While uncommon, TMA is one of the most serious complications of SLE and in many cases may be resistant to therapy. We report a patient with SLE complicated by TMA that was refractory to standard therapy but responded well to eculizumab, with continued remission after 1 year of follow-up. Eculizumab might be useful in the management of resistant cases of TMA caused by SLE.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Amr MD, Schot MD, Ahmed MD, Stuart MD, Virgilius MD, B. Peter MD,